e-learning
resources
2020
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Personalised exhaled nitric oxygen fraction (
F
ENO
)-driven asthma management in primary care: a
F
ENO
subgroup analysis of the ACCURATE trial
Suzanne Boer, Persijn J. Honkoop, Rik J.B. Loijmans, Jiska B. Snoeck-Stroband, Willem J.J. Assendelft, Tjard R.J. Schermer, Jacob K. Sont
Source:
ERJ Open Res, 6 (3) 00351-2019; 10.1183/23120541.00351-2019
Journal Issue:
July
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Suzanne Boer, Persijn J. Honkoop, Rik J.B. Loijmans, Jiska B. Snoeck-Stroband, Willem J.J. Assendelft, Tjard R.J. Schermer, Jacob K. Sont. Personalised exhaled nitric oxygen fraction (
F
ENO
)-driven asthma management in primary care: a
F
ENO
subgroup analysis of the ACCURATE trial. ERJ Open Res, 6 (3) 00351-2019; 10.1183/23120541.00351-2019
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
The impact of fractional exhaled nitric oxide (FeNO) measurement on treatment decision making in the specialist care of established asthma
Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases
Year: 2013
Cost savings using fractional exhaled nitric oxide (FeNO) testing in asthma management by specialists
Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases
Year: 2013
Clinical utility of exhaled nitric oxide fraction in the management of asthma and COPD
Source: Breathe, 15 (4) 306; 10.1183/20734735.0268-2019
Year: 2019
Opinions towards the implementation of spirometry and exhaled nitric oxide testing in children under investigation for asthma in primary care
Source: International Congress 2018 – Paediatric asthma: new mechanisms and tools
Year: 2018
Meta analysis of asthma exacerbation rates in adult and pediatric asthmatics managed using fractional exhaled nitric oxide versus standard clinical parameters alone
Source: Annual Congress 2013 –Asthma and COPD management: novel clinical findings
Year: 2013
Does treatment guided by exhaled nitric oxide fraction improve outcomes in subgroups of children with asthma?
Source: Eur Respir J, 55 (5) 1901879; 10.1183/13993003.01879-2019
Year: 2020
Usefulness of fraction of exhaled nitric oxide and asthma management questionnaires in predicting a future risk of asthma exacerbation
Source: International Congress 2019 – FeNO in airway diseases and asthma-COPD overlap identification
Year: 2019
The assessment of exhaled nitric oxide fraction in monitoring asthma control: How to raise the clinical relevance?
Source: Annual Congress 2010 - Cough, airway hyperresponsiveness and asthma control
Year: 2010
Educational intervention decreases exhaled nitric oxide in farmers with occupational asthma
Source: Eur Respir J 2007; 30: 545-548
Year: 2007
Economic evaluation of fractional exhaled nitric oxide (FENO) for the management of adult asthma in Spain
Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease
Year: 2015
Exhaled nitric oxide (FeNO) levels to guide treatment for adults with asthma: A Cochrane systematic review
Source: International Congress 2016 – Inflammatory biomarkers in airway diseases
Year: 2016
Does the measurement of exhaled nitric oxide before and after specific inhalation challenges improve the diagnosis of occupational asthma?
Source: International Congress 2019 – Occupational lung diseases: from diagnostic techniques to classical and novel causes
Year: 2019
Domiciliary diurnal variation of fractional exhaled nitric oxide (FeNO) to monitor asthma control
Source: Annual Congress 2013 –Diagnosis and management of respiratory diseases
Year: 2013
High occurrence of elevated exhaled nitric oxide (eNO) in non-atopic patients attending a specialist respiratory clinic
Source: Eur Respir J 2003; 22: Suppl. 45, 457s
Year: 2003
Improvement of asthma control assessed by exhaled nitric oxide: a real-life longitudinal study
Source: Eur Respir J 2005; 26: Suppl. 49, 276s
Year: 2005
Exhaled nitric oxide (FeNO) levels to guide treatment for children with asthma: A Cochrane systematic review
Source: International Congress 2016 – Techniques and tools in paediatric asthma
Year: 2016
Interaction between airway calibre and exhaled NO: Impact on asthma control assessment
Source: Annual Congress 2013 –Diagnosis and management of respiratory diseases
Year: 2013
An eye to the future: exhaled nitric oxide as a predictor of clinical outcomes in asthma
Source: Eur Respir J 2010; 35: 1200-1202
Year: 2010
Asthma exacerbations and exhaled nitric oxide: a randomised controlled trial
Source: Eur Respir J 2006; 28: Suppl. 50, 572s
Year: 2006
Exhaled nitric oxide predicts control in patients with difficult-to-treat asthma
Source: Eur Respir J 2010; 35: 1221-1227
Year: 2010
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept